These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2951574)
1. Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats. Barrett RJ; Wright KF; Taylor DR; Proakis AG Life Sci; 1987 Apr; 40(15):1499-506. PubMed ID: 2951574 [TBL] [Abstract][Full Text] [Related]
2. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission. Hietala J J Auton Pharmacol; 1988 Dec; 8(4):297-302. PubMed ID: 2855331 [TBL] [Abstract][Full Text] [Related]
3. Role of dopamine1-receptors in mediating renal responses to furosemide in the rat. Nowicki S; Enero MA Gen Pharmacol; 1991; 22(3):459-63. PubMed ID: 1831170 [TBL] [Abstract][Full Text] [Related]
4. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes. Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247 [TBL] [Abstract][Full Text] [Related]
5. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. LaHoste GJ; Marshall JF Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015 [TBL] [Abstract][Full Text] [Related]
6. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Hiroi N; White NM Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032 [TBL] [Abstract][Full Text] [Related]
7. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. Missale C; Memo M; Liberini P; Spano P J Pharmacol Exp Ther; 1988 Sep; 246(3):1137-43. PubMed ID: 2458445 [TBL] [Abstract][Full Text] [Related]
8. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism]. Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371 [TBL] [Abstract][Full Text] [Related]
9. Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa. Missale C; Liberini P; Memo M; Carruba MO; Spano P Endocrinology; 1986 Nov; 119(5):2227-32. PubMed ID: 3533523 [TBL] [Abstract][Full Text] [Related]
10. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats. Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization. Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369 [TBL] [Abstract][Full Text] [Related]
12. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists. Boyar WC; Altar CA J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060 [TBL] [Abstract][Full Text] [Related]
13. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys. Sowers JR Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects? Ljungberg T J Neural Transm; 1989; 76(2):79-90. PubMed ID: 2565360 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. Sowers JR; Beck FW Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674 [TBL] [Abstract][Full Text] [Related]
16. Participation of periventricular dopamine receptors in vasopressin secretion elicited by hypertonicity of systemic blood in rats. Yamaguchi K; Hama H Acta Endocrinol (Copenh); 1991 Apr; 124(4):455-62. PubMed ID: 2031443 [TBL] [Abstract][Full Text] [Related]
18. Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion. Słowińska-Srzednicka J; Puciłowska J; Zgliczyński S Clin Exp Hypertens A; 1987; 9(11):1843-58. PubMed ID: 2830067 [TBL] [Abstract][Full Text] [Related]
19. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
20. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response? Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]